- \n
- First quarter GAAP EPS of $0.06; non-GAAP diluted EPS of $0.19<\/i><\/b><\/li>\n
- First quarter bookings of $194 million up 6% from the first quarter of 2020 <\/i><\/b><\/li>\n
- Generated $56 million of cash flow from continuing operations and $35 million of free cash flow in the first quarter<\/i><\/b><\/li>\n<\/ul>\n
CHICAGO–(BUSINESS WIRE<\/a>)–
\nAllscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2021.\n<\/p>\n\nBookings(1)<\/sup> were $194 million in the first quarter of 2021. This result compares with $183 million in the first quarter of 2020. Contract revenue backlog totaled $4.0 billion as of March 31, 2021.\n<\/p>\n
\nFirst quarter 2021 revenue was $368 million compared with $381 million in the first quarter of 2020.\n<\/p>\n
\nOn a GAAP basis in the first quarter of 2021, income from operations was $13 million compared with a GAAP loss from operations in the first quarter of 2020 of $27 million. Non-GAAP income from operations in the first quarter of 2021 was $38 million compared with $8 million in the first quarter of 2020.\n<\/p>\n
\nGAAP net income in the first quarter of 2021 totaled $9 million compared with net loss of $20 million in the first quarter of 2020. Non-GAAP net income in the first quarter of 2021 was $28 million compared with $3 million in the first quarter of 2020.\n<\/p>\n
\nGAAP earnings per share in the first quarter of 2021 was $0.06 compared with loss per share of $0.20 in the first quarter of 2020. Non-GAAP diluted earnings per share in the first quarter of 2021 was $0.19 compared with $0.02 in the first quarter of 2020.\n<\/p>\n
\nAdjusted EBITDA totaled $67 million in the first quarter of 2021, compared with $37 million in the first quarter of 2020.\n<\/p>\n
\n\u201cEntering 2021, Allscripts continued to benefit from our strategic investments in distinctive, relevant and comprehensive solutions for our clients across the provider, payer and life sciences end markets. While regional uncertainty remains regarding the trajectory of COVID-19, we are optimistic as the pace of vaccinations increases, patient volumes recover, and we see expanded demand for closed loop connectivity to real world data,\u201d said Paul M. Black, Allscripts Chief Executive Officer. \u201cWe were pleased with our strong first quarter results, as we gained from a more robust selling environment and a determined discipline around our cost structure. Looking forward expect a steady, purposeful focus on improving margins, generating free cash flow and serving our clients as they lead their organizations through the pandemic.\u201d\n<\/p>\n
2021 Financial Outlook(2)<\/sup><\/b><\/p>\n
\nAllscripts is affirming its prior annual outlook and currently expects to achieve:\n<\/p>\n
- \n
- \nRevenue of $1.5 billion\n<\/li>\n
- \nAdjusted EBITDA between $240 million and $260 million\n<\/li>\n
- \nFree cash flow between $90 million and $100 million\n<\/li>\n<\/ul>\n
Conference Call<\/b><\/p>\n
\nAllscripts will conduct a conference call today, Thursday, April 29th, 2021, at 4:30 PM Eastern Time to discuss its earnings release and other information. Participants may access the conference call via webcast at http:\/\/investor.allscripts.com<\/a>. Participants also may access the conference call by dialing +1 (877) 269-7756 or +1 (201) 689-7817 (international) and requesting Conference ID # 13718264.\n<\/p>\n\n
\nA replay of the call will be available approximately two hours after the conclusion of the call, for a period of four weeks, on the Allscripts Investor Relations website or by calling +1 (877) 660-6853 or +1 (201) 612-7415 – Conference ID # 13718264.\n<\/p>\n
\nSupplemental and non-GAAP financial information is also available at http:\/\/investor.allscripts.com<\/a>.\n<\/p>\n
Footnotes<\/b><\/p>\n
- First quarter bookings of $194 million up 6% from the first quarter of 2020 <\/i><\/b><\/li>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20210429005963\/en\/745337\/3\/Allscripts-Logo.jpg\"){kind=logo}
<\/td>\n<\/tr>\n